[ORGANIZATION]
IM1240
Featured in 1 tracked story · first seen
Situations
Jazz Pharmaceuticals Ziihera oncology developments
2 clusters · 2 sources · last updated
Latest: Jazz Pharmaceuticals launches Ziihera following FDA approval for GEA
In August 2026, Jazz Pharmaceuticals and Purple Biotech reported significant developments in oncology. Jazz Pharmaceuticals published Phase 3 trial results for Ziihera (zanidatamab-hrii) in the New England Journal of Med